Immobilization, muscle wasting
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Healthy males, between the ages of 18 and 30 y 2) BMI between 18.5 and 30.0 kg/m2 3) Able and willing to provide informed consent
Exclusion criteria
Exclusion criteria: 1) The use of anti-inflammatory and/or analgesic medication, whether it is prescription or not 2) A history of neuromuscular disorders or muscle/bone wasting diseases 3) Any acute or chronic illness, cardiac, pulmonary, liver, or kidney abnormalities, uncontrolled hypertension, insulin-dependent or insulin-independent diabetes, or the presence of any other metabolic disease – all of which will be determined via a medical history screening questionnaire 4) The use of any medications known to affect protein metabolism (glucocorticoids, non-steroidal anti-inflammatory medication, or prescription strength acne medication, etc.) 5) A (family) history of thrombosis 6) The use of anticoagulant medications 7) Consumption of tobacco-containing products 8) Excessive alcohol consumption (>21 units/wk) 9) History of bleeding diathesis, platelet or coagulation disorders, or antiplatelet/anticoagulation therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)The effect of single leg immobilization on basal and postprandial skeletal muscle protein synthesis 2)The effect of single leg immobilization on basal and postprandial skeletal muscle protein breakdown 3)The effect of single leg immobilization on rates of skeletal muscle glucose uptake | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) The effect of single leg immobilization on muscle mass, muscle strength, and body composition 2) The effect of single leg immobilization on integrated (chronic) rates of muscle protein synthesis | — |
Contacts
Department of Kinesiology - McMaster University